<?xml version="1.0" encoding="UTF-8"?>
<p id="Par52">Current epidemiological data indicate that children and younger adults have been deeply infected with the 2009 pandemic influenza A [
 <xref ref-type="bibr" rid="CR92">92</xref>]. Therefore, children should be the primary target group for vaccination. According to the American Academy of Pediatrics, the vaccine must be included in the repetitive immunization regimen for children aged 5 to 18 years [
 <xref ref-type="bibr" rid="CR93">93</xref>]. The study showed that LAIV was 82% effective against pandemic influenza A in children 2–8 years of age and that its efficacy decreased by 11% in children 9–17 years of age [
 <xref ref-type="bibr" rid="CR94">94</xref>].
</p>
